Options Data for US Stocks: End-of-Day and Historical Learn more

Regenxbio Inc icon

Regenxbio Inc (RGNX NASDAQ) stock market data APIs

$7.3009 0.11(1.5%)
as of November 17, 2026
Try our APIs with free plan!

Regenxbio Inc Financial Data Overview

Price chart is built with Anychart

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202 for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 and with Nippon Shinyaku Co., Ltd. to develop RGX-121 and RGX-111 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.

Prev. Close 7.3009
Open 7.4109
High 7.4741
Low 6.7799
52 wk Range 5.455-16.19
Market Cap 459 M
Shares Outstanding 66 123 K
Revenue 154 M
EPS -0.62
Beta 1.228

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Regenxbio Inc (top by weight)

Ticker
100-day Price Change
Weight
FBDIX.US FRANKLIN BIOTECHNOLOGY DISCOVERY FUND CLASS A
-23.61 (-11.57%)
1.47
BBC.US Virtus LifeSci Biotech Clinical Trials ETF
-12.35 (-23.51%)
0.90
WDNA.US WisdomTree BioRevolution Fund
0.71 (3.39%)
0.52
GNOM.US Global X Genomics & Biotechnology ETF
0.83 (1.42%)
0.29
BIS.US ProShares UltraShort Nasdaq Biotechnology
-1.29 (-10.29%)
0.21
SCDS.US JPMorgan Fundamental Data Science Small Core ETF
-6.94 (-9%)
0.21

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Regenxbio Inc data using free add-ons & libraries


Get Regenxbio Inc Fundamental Data

Regenxbio Inc logo

Regenxbio Inc Fundamental data includes:

  • Net Revenue: 154 M
  • EBITDA: -170 296 992
  • Earnings Per Share: -3
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Regenxbio Inc Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-11-05
  • EPS/Forecast: -1.35
GET THE PACKAGE

Get Regenxbio Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Regenxbio Inc News

Get Regenxbio Inc fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE

Send the request

Leave your email and our team will contact you ASAP.